GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer

BACKGROUND: Basal-like breast cancer (BLBC) takes up about 10–20% of all breast cancer(BC), what’s more, BLBC has the lowest survival rate among all BC subtypes because of lacks of efficient treatment methods. We aimed to explore the molecules that can be used as diagnostic maker for BLBC at early s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Liang, Zhang, Yue, Zheng, Chunlei, Zhao, Fuqiang, Lin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386636/
https://www.ncbi.nlm.nih.gov/pubmed/37507701
http://dx.doi.org/10.1186/s12905-023-02547-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386636/
https://www.ncbi.nlm.nih.gov/pubmed/37507701
http://dx.doi.org/10.1186/s12905-023-02547-1

Ejemplares similares